JDD Issue Highlights | April 2022
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD … 
Chemical peels are the third most commonly performed noninvasive cosmetic procedure in the United States, with over 1 million peels performed annually.
Peels can treat a variety of skin conditions including acne, conditions of hyperpigmentation, and skin irregularities from chronic sun damage. Multiple peels on a repeated basis are usually necessary to obtain optimal results. The frequency of … 
Hydroquinone is the most commonly used depigmentation agent and is a first-line treatment for melasma.1Hydroquinone was available previously in over-the-counter products and is currently available in prescription formulations with common concentration ranges of 0.4 to 5%. Prescription strengths available in the United States include hydroquinone 2% and 4% cream and hydroquinone 2% gel.2,3 In Septe … 
Acne scarring affects many of our acne patients and can lead to a great impact on quality of life and self-esteem. Treating acne scars aggressively in skin of color patients can be challenging, given the risk of side effects associated with different procedures. In her lecture entitled: Combining Lasers & Treatments for Acne Scars in Patients with Skin of Color – This is How I Do It, Dr. DiA … 
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associ … 